Concepedia

Winston Evering

WE

15

Publications

796

Citations

14

H-Index

1990

Active since

Affiliations

Pfizer (United States)(Current)

University of Liverpool

Covance (United States)

Winston Evering is an author at Pfizer (United States) specializing in pharmacology, medicine, and toxicology.

ORCID

Top concepts

Publications per year

1990–2019

15

Publications

15

Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Shihao Chen, Li‐Fen Lee, Timothy S. Fisher et al. · Cancer Immunology Research · 2014 · 270 citations · Full text

IL-7 Promotes T <sub>H</sub> 1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis

Li‐Fen Lee, Robert C. Axtell, Guang Huan Tu et al. · Science Translational Medicine · 2011 · 112 citations

Nonclinical Safety Evaluation of Sunitinib: A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET Receptors

Shem Patyna, Claudio Arrigoni, Andrea Terron et al. · Toxicologic Pathology · 2008 · 89 citations

, , +16

Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer

Guoyun Zhu, Davide Foletti, Xiaohui Liu et al. · Scientific Reports · 2019 · 70 citations · Full text

Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper‐loaded rats

Winston Evering, S. Haywood, Margaret E. Elmes et al. · The Journal of Pathology · 1990 · 41 citations

Rows per page

1–5 of 15